“Cannabis use was associated with a 40 percent hazard reduction in alcohol-associated steatosis, hepatitis, fibrosis, and cirrhosis, and a 14 percent reduction in all-cause mortality.”
Search Results for: liver disease
Investigators concluded, “In this nationally representative sample, current marijuana use is inversely associated with steatosis.”
“CBD administration decreased daytime drowsiness and was associated with a lower prevalence of low testosterone levels in older men as compared to age-adjusted population norms,” investigators concluded.
Santander, Spain: Subjects with a history of cannabis use are less likely than abstainers to…
Cannabis use is not linked to either hepatic fibrosis or non-alcoholic fatty liver disease (NAFLD).
Cannabis use appears to be protective against liver disease progression in subjects who frequently consume alcohol.
Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease
Adults with a history of cannabis use are less likely to suffer from non-alcoholic fatty liver disease (NAFLD) than are those who have not used the substance, according to data published online in the journal PLoS One. “Active marijuana use provided a protective effect against NAFLD independent of known metabolic risk factors,” authors determined. “[W]e conclude that current marijuana use may favorably impact the pathogenesis of NAFLD in US adults.”